American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation
- 1 June 2023
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 164 (7), 1086-1106
- https://doi.org/10.1053/j.gastro.2023.03.214
Abstract
No abstract availableFunding Information
- Takeda Pharmaceutical Company
- International Foundation for Functional Gastrointestinal Disorders
- National Institutes of Health
- U.S. Food and Drug Administration
- Fondazione Roma
This publication has 75 references indexed in Scilit:
- Association of Low Dietary Intake of Fiber and Liquids With Constipation: Evidence From the National Health and Nutrition Examination SurveyThe American Journal of Gastroenterology, 2013
- Fiber and Prebiotics: Mechanisms and Health BenefitsNutrients, 2013
- High amplitude propagated contractionsNeurogastroenterology & Motility, 2012
- Prucalopride in the treatment of chronic constipation in patients from the Asia‐Pacific region: a randomized, double‐blind, placebo‐controlled studyNeurogastroenterology & Motility, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Two Randomized Trials of Linaclotide for Chronic ConstipationThe New England Journal of Medicine, 2011
- Efficacy and Safety of Lubiprostone in Patients with Chronic ConstipationDigestive Diseases and Sciences, 2009
- Is Senna Laxative Use Associated to Cathartic Colon, Genotoxicity, or Carcinogenicity?Journal of Toxicology, 2009
- Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2008
- Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxativesGut, 2008